International Stem Cell Corporation’s Human Parthenogenetic Stem Cells to be used in the Development of Treatments for Liver Disease

OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB:ISCO) announced today that its human parthenogenetic stem cell lines will be used in studies aimed at creating liver cells to treat human liver disease.